Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
48.81
-1.09 (-2.18%)
Nov 21, 2024, 12:24 PM EST - Market open
Doximity Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Doximity stock have an average target of 50.43, with a low estimate of 30 and a high estimate of 75. The average target predicts an increase of 3.32% from the current stock price of 48.81.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Doximity stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 0 | 1 | 2 | 4 |
| Hold | 9 | 8 | 7 | 7 | 6 | 9 |
| Sell | 1 | 2 | 2 | 2 | 2 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 12 | 12 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Initiates $58 | Hold | Initiates | $58 | +18.83% | Nov 15, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $35 → $49 | Hold | Maintains | $35 → $49 | +0.39% | Nov 14, 2024 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $33 → $53 | Sell → Hold | Upgrades | $33 → $53 | +8.58% | Nov 14, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $40 → $60 | Strong Buy → Hold | Downgrades | $40 → $60 | +22.93% | Nov 13, 2024 |
| Barclays | Barclays | Buy Maintains $52 → $75 | Buy | Maintains | $52 → $75 | +53.66% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
535.78M
from 475.42M
Increased by 12.70%
Revenue Next Year
586.56M
from 535.78M
Increased by 9.48%
EPS This Year
1.08
from 0.72
Increased by 50.11%
EPS Next Year
1.15
from 1.08
Increased by 6.57%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 566.9M | 625.7M | 703.3M | ||
| Avg | 535.8M | 586.6M | 634.7M | ||
| Low | 504.8M | 545.3M | 580.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.2% | 16.8% | 19.9% | ||
| Avg | 12.7% | 9.5% | 8.2% | ||
| Low | 6.2% | 1.8% | -1.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.21 | 1.30 | 1.61 | ||
| Avg | 1.08 | 1.15 | 1.30 | ||
| Low | 0.97 | 1.03 | 1.17 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 67.7% | 20.5% | 39.5% | ||
| Avg | 50.1% | 6.6% | 13.1% | ||
| Low | 34.8% | -4.8% | 1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.